Page 43 - Clinical Development News Today

Sepehr Shojaei serves as the vice president of design solutions at Lightship, using his 15 years of experience in clinical research operations to champion a patient-centric approach.

Colleen Acosta is CEO of Freya Biosciences which is a trans-Atlantic clinical-stage biotech company pioneering microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of women’s reproductive system conditions and we were excited to put our Women in Science questions to her.

Andrew Mills, executive vice president of global commercial Lokavant and says the company can help businesses identify risk trends in trials much earlier than traditional methods.

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The

OM1 says it wants to stand at the helm of a healthcare revolution, fostering an integrated approach to generating and utilizing real-world evidence (RWE), reshaping the foundation of healthcare.

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "WEGOVY Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed picture of the WEGOVY for osteoarthritis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, along with Canada, and Korea for the study period 2019 -2032 is provided in this report along with a detailed description of the WEGOVY for osteoart...

Elisa Cascade is chief product officer at Advarra, a business that says it aims to advance the way clinical research is conducted by bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration.